Medical Specialist I - North Dakota & South Dakota
Regeneron Pharmaceuticals
Summary
The Medical Specialist (Sales Representative), Pulmonology (MS) will be responsible for engaging Pulmonologists and other key customers within an assigned geography, presenting clinically focused selling messages to create and grow revenue, and consistently delivering product goals. The MS will demonstrate strong and consistent sales performance that exceeds forecast and expectations related to product goals. The MS will accomplish this in a compliant manner with a high degree of integrity strictly following all Regeneron policies and in compliance with all policies and procedures governing the promotion of pharmaceutical and biologic products in the US.
Job description
When & where:
- Field Role
- Location: North Dakota & South Dakota
Discover your role:
- Developing strategy and implementing tactics within key accounts in our Pulmonary therapeutic areas to generate product utilization.
- Establishing and fostering strong relationships with Pulmonary health care professionals. This will include physicians, advanced practitioners, nurses, office staff and other important personnel as well as key patient advocacy support groups.
- Collaborating with regional colleagues, as well as other field-based and home office teams to proactively address customer needs.
- Analyzing market dynamics and trends to develop strategies which support brand and corporate objectives.
- Participating in initiatives to support sales success such as industry-related congresses, local and regional meetings and medical conferences.
This role requires:
- You will need a bachelor’s degree (required); Specialty pharmaceutical/biopharmaceutical experience with a minimum of 5 years pharmaceutical sales experience.
- A minimum of 2 years selling in the Respiratory market and/or a similar subcutaneous self-injectable biologic specialty market also required.
- Demonstrate advanced clinically-based selling skills and be results oriented with a proven track record of success with product launches.
- Experience with in-servicing and training office staff, nurses and office managers and the ability to partner and collaborate with other internal field teams and alliance partners.
- Ability to travel and cover large geographic territories.
Requirements
- Bachelor's degree
- Minimum of 5 years pharmaceutical sales experience
- Minimum of 2 years selling in Respiratory market and/or similar subcutaneous self-injectable biologic specialty market
- Advanced clinically-based selling skills
- Proven track record of success with product launches
- Experience with in-servicing and training office staff, nurses and office managers
- Ability to partner and collaborate with internal field teams and alliance partners
- Ability to travel and cover large geographic territories
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.